US medical device and life sciences leader GE Healthcare Technologies Inc. (NASDAQ: GEHC) has announced the receipt of FDA 510(k) clearance for its innovative SIGNA MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner. This clearance marks a significant advancement in medical imaging technology, offering new capabilities for the detection and analysis of neurological, oncological, and psychiatric conditions.
SIGNA MAGNUS: Technical Innovations
The SIGNA MAGNUS MRI scanner features an innovative asymmetrical, high-efficiency, head-only gradient coil design that facilitates easier patient head access and accommodates shoulder-width limitations. This design significantly reduces Peripheral Nerve Stimulation (PNS), enhancing patient comfort and safety during the imaging process.
Advanced Imaging Capabilities
With a gradient amplitude and slew rate that surpass those of conventional 60cm or 70cm bore whole-body MRI systems, the SIGNA MAGNUS allows for high-resolution, high signal-to-noise ratio imaging. This advanced capability supports detailed clinical imaging and biomarker research, providing insights that have been challenging to achieve with traditional MRI systems. The system is particularly suited for advanced imaging of the brain, making it a valuable tool in the fields of clinical imaging and neuroscience.-Fineline Info & Tech
Leave a Reply